Novatio Ventures
Novatio Ventures is a venture capital firm accelerating the commercialization of life science innovations. The firm's focus is on the development of innovations and other markets that represents a significant source of opportunities for outsized value creation. It invests in firms operating in therapeutics, diagnostics, devices, and drug delivery technologies. They target early-stage innovation on the transition of preclinical proof-of-concept or validation and provides seed funding and work actively with inventors, entrepreneurs, and institutions to devise and implement development and commercialization strategies, assemble management teams, and secure additional capital. It aims to leverage their collective experience and industry network to achieve early exits that generate attractive, risk-mitigated financial returns. Peng Fu established the firm in Toronto, Ontario in 2015.
Winterlight Labs builds technology that can quickly and accurately detect signs of cognitive impairment from a sample of speech. WinterLight Labs develops a novel AI technology platform that can quickly and accurately quantify speech and language patterns to help detect and monitor cognitive and mental diseases. This platform can analyze natural speech to detect and monitor dementia, aphasia, and various cognitive conditions. Using a short one-minute sample of speech, WinterLight can characterize the speaker's cognitive, acoustic, and linguistic state, including lexical diversity, syntactic complexity, semantic content, and articulation. Winterlight was founded in 2015 and is based in Toronto, Canada.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.